Analysis of relationships between pathogenesis of hematological diseases and activated platelets

Analysis of relationships between pathogenesis of hematological diseases and activated platelets - Hematological diseases and activated platelets

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036644

Enrollment

200

Registered

2019-05-07

Start date

2019-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematological diseases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are diagnosed with hematological diseases, including hematological malignancy, aplastic anemia, and immune thrombocytopenia

Exclusion criteria

Exclusion criteria: Patients with severe anemia who need red blood cell transfusion. Patients received platelet transfusion within one week.

Design outcomes

Primary

Measure	Time frame
Expression levels of platelet P-selectin and activated alphaIIb be-ta3	—

Secondary

Measure	Time frame
VWF antigen, VWF activity, Thrombogenic assay, Bleeding symptom, Occurrence of thrombosis	—

Countries

Japan

Contacts

Public ContactKenji Yokoyama

Tokai University Hachioji Hospital Department of Hematology/Oncology

yk092750@tsc.u-tokai.ac.jp042-639-1111

Outcome results